NAVB
Navidea Biopharmaceuticals Inc.
NAVB
NAVB
Delisted
NAVB was delisted on the 5th of October, 2023.
56 hedge funds and large institutions have $5.76M invested in Navidea Biopharmaceuticals Inc. in 2017 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 13 increasing their positions, 13 reducing their positions, and 0 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
Holders
56
Holding in Top 10
–
Calls
$24K
Puts
$19K
Top Buyers
| 1 | +$92K | |
| 2 | +$33K | |
| 3 | +$23.4K | |
| 4 |
Jane Street
New York
|
+$19.4K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$17.6K |
Top Sellers
| 1 | -$359K | |
| 2 | -$103K | |
| 3 | -$102K | |
| 4 |
Goldman Sachs
New York
|
-$15.2K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$15.1K |